Fetal fibronectin does not affect outcomes of preterm labourBMJ 2004; 328 doi: https://doi.org/10.1136/bmj.328.7455.0-f (Published 24 June 2004) Cite this as: BMJ 2004;328:0-f
Question Does use of fetal fibronectin in management of preterm labour affect age at delivery or rates of interventions?
Synopsis Fetal fibronectin evaluation has been introduced to try to discriminate between women who are more or less likely to deliver preterm on presentation to labour and delivery for symptoms of preterm labour. It has not been shown to influence outcomes. Women at 23 to 34 weeks' gestation …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial